Latest news
Loading news…
Nektar Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Francisco, California, United States Founded 1990 101-250 employees For Profit
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Nektar Therapeutics was acquired by Ampersand Capital Partners in 2024.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Investments
1
1 exits
Monthly Visits
Available in Pro Contacts
529
Ticker
NKTR
NASDAQ
Patents
343
16 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- NKTR
- Exchange
- NASDAQ
- IPO date
- May 13, 1994
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- Active products
- 23
- Patents granted
- 343
- Trademarks
- 16
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1M
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
- Exits
- 1
Company Info
- Founded
- 1990
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- News articles
- 614
- Events
- 1
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- May 13, 1994
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- -0.1
- Trend (30d)
- -2.3
- Trend (90d)
- -2.7
- Last leadership hire
- Jun 19, 2026
- Last layoff mention
- Apr 17, 2023
Investments by Nektar Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Nektar Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Nektar Therapeutics
President and Chief Executive Officer
Senior Vice President, Human Resources and Facilities Operations
Senior Vice President and Chief Medical Officer
SVP Finance & Chief Accounting Officer
Chief Research and Development Officer
Chief Commercial Officer
Member of the Board of Directors
Member of the Board of Directors
Senior Vice President and Chief Medical Officer
Member of the Board of Directors
Senior Vice President, Technology Assessment and Quality Assurance
SVP, Strategy and Corporate Affairs
Member of the Board of Directors
Vice President, Head of Operations Europe
529
professional contacts at Nektar Therapeutics
Contact execs at Nektar Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Nektar Therapeutics
Loading news…
FAQs about Nektar Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.